A Novel Vaccine Approach

"A New Approach to the Flu Vaccine"

News was just released allowing United States technology the ability to create a new flu vaccine to develop a new protein vaccine against the influenza virus.  The United States has entered an exclusive license agreement with Academia Sinica is Taiwan. They plan to work collaboratively to come up with the first product that will serve as a vaccination to all strains of the flu. 

Both parties will be working closely to develop a protein based flu vaccine that will react to H1, H3, and H5 strains of the flu.  This is opposed to the usual implementation of the inactivated flu vaccine each season.  This will help to stop mutating strains of the virus before it has the chance to infect millions of people.  This will help the medical industry get a jump start on the world of infectious diseases.

Valid XHTML 1.0 Transitional